Choroidal Microvascular Dropout in Pseudoexfoliation Glaucoma.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
01 05 2019
Historique:
entrez: 21 5 2019
pubmed: 21 5 2019
medline: 15 10 2019
Statut: ppublish

Résumé

To compare the prevalence of choroidal microvasculature dropout (CMvD) in pseudoexfoliation glaucoma (PXG) and disease severity-matched primary open-angle glaucoma (POAG) eyes. In a cross-sectional study, 39 eyes with PXG (33 patients) and 39 glaucoma severity-matched POAG eyes (34 patients) underwent visual fields, optical coherence tomography and optical coherence tomography angiography examination. Peripapillary vessel density (VD) was evaluated from the radial peripapillary capillary slab, parafoveal VD was measured on the superficial vascular plexus slab of the macula, and CMvD was evaluated on the choroidal slabs of the optic disc scan. The PXG and POAG groups were similar with respect to average mean deviation on visual fields (-12.1 vs. -12.0 decibel, P = 0.96) and average peripapillary retinal nerve fiber layer thickness on optical coherence tomography (71 vs. 74 μ, P = 0.29). Average peripapillary superficial VD (49.7% vs. 51.3%, P = 0.35) and parafoveal VD (44.8% vs. 45.8%, P = 0.33) were similar between the PXG and POAG groups. CMvD was seen in 18 PXG and 31 POAG eyes (46.2% vs. 79.5%, P = 0.002). On multivariate analysis that accounted for the severity of glaucoma, the odds of CMvD was significantly lower in the PXG group when compared with the POAG group (odds ratio: 0.18-0.21, P < 0.01). The prevalence of CMvD was significantly lower in the PXG eyes when compared with the POAG eyes.

Identifiants

pubmed: 31108546
pii: 2734477
doi: 10.1167/iovs.19-26844
pmc: PMC6528839
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2146-2151

Subventions

Organisme : NEI NIH HHS
ID : R01 EY029058
Pays : United States

Références

JAMA Ophthalmol. 2015 Sep;133(9):1045-52
pubmed: 26203793
Graefes Arch Clin Exp Ophthalmol. 2015 Sep;253(9):1557-64
pubmed: 26255817
Ophthalmology. 2016 Dec;123(12):2509-2518
pubmed: 27769587
Am J Ophthalmol. 2006 May;141(5):921-937
pubmed: 16678509
J Glaucoma. 2018 Feb;27(2):189-196
pubmed: 29271810
Ophthalmology. 2000 Oct;107(10):1809-15
pubmed: 11013178
Am J Ophthalmol. 2019 Mar;199:184-192
pubmed: 30552893
J Glaucoma. 2018 Nov;27(11):1009-1016
pubmed: 30134370
Ophthalmology. 2014 Jul;121(7):1322-32
pubmed: 24629312
Invest Ophthalmol Vis Sci. 2011 Mar 10;52(3):1290-6
pubmed: 20811060
Ophthalmology. 2010 Sep;117(9):1692-9, 1699.e1
pubmed: 20493529
Asia Pac J Ophthalmol (Phila). 2018 Mar-Apr;7(2):84-89
pubmed: 29165935
Biomed Opt Express. 2012 Dec 1;3(12):3127-37
pubmed: 23243564
Opt Express. 2012 Feb 13;20(4):4710-25
pubmed: 22418228
Biometrics. 2000 Jun;56(2):645-6
pubmed: 10877330
Ophthalmology. 2018 Apr;125(4):588-596
pubmed: 29224927
Am J Ophthalmol. 2016 Nov;171:75-83
pubmed: 27590118
J Ophthalmol. 2016;2016:6956717
pubmed: 26998352
Prog Brain Res. 2008;173:211-24
pubmed: 18929111
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT451-9
pubmed: 27409505
Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1621-1627
pubmed: 28297027
J Glaucoma. 2018 Aug;27(8):e137-e139
pubmed: 29762268
Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):3004-3010
pubmed: 28605811
J Glaucoma. 2017 Jun;26(6):548-554
pubmed: 28333896
Ophthalmology. 2001 Jun;108(6):1043-9
pubmed: 11382627
Arch Ophthalmol. 1992 Mar;110(3):381-7
pubmed: 1543458

Auteurs

Zia S Pradhan (ZS)

Narayana Nethralaya, Rajajinagar, Bangalore, India.

Harsha L Rao (HL)

Narayana Nethralaya, Rajajinagar, Bangalore, India.
Narayana Nethralaya, Hulimavu, Bangalore, India.

Shivani Dixit (S)

Narayana Nethralaya, Rajajinagar, Bangalore, India.

Shruthi Sreenivasaiah (S)

Narayana Nethralaya, Rajajinagar, Bangalore, India.

Praveena G Reddy (PG)

Narayana Nethralaya, Rajajinagar, Bangalore, India.

Jayasree P Venugopal (JP)

Narayana Nethralaya, Rajajinagar, Bangalore, India.

Narendra K Puttaiah (NK)

Narayana Nethralaya, Rajajinagar, Bangalore, India.
Narayana Nethralaya, Hulimavu, Bangalore, India.

Sathi Devi (S)

Narayana Nethralaya, Rajajinagar, Bangalore, India.

Robert N Weinreb (RN)

Shiley Eye Institute, Hamilton Glaucoma Center and Department of Ophthalmology, University of California, San Diego, California, United States.

Kaweh Mansouri (K)

Glaucoma Center, Montchoisi Clinic, Swiss Vision Network, Lausanne, Switzerland.
Department of Ophthalmology, University of Colorado, Denver, Colorado, United States.

Carroll A B Webers (CAB)

University Eye Clinic Maastricht, University Medical Center, Maastricht, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH